Europäische Union - Deutsch - EMA (European Medicines Agency)

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastische mittel - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

elpen pharmaceutical co. inc. beiname: elpen, elpen s.a., elpen a.e. (8066783) - tiotropium - einzeldosiertes pulver zur inhalation - 10 µg - tiotropium (36753) 0,013 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

h e x a l aktiengesellschaft (3079284) - budesonid; formoterolfumarat-dihydrat (ph.eur.) - einzeldosiertes pulver zur inhalation - 320 mikrogramm/9 mikrogramm - teil 1 - einzeldosiertes pulver zur inhalation; budesonid (18667) 346,3 mikrogramm; formoterolfumarat-dihydrat (ph.eur.) (23761) 10,8 mikrogramm